Stock listing
PMVP Stock Price, News, Filings & Events — Pmv Pharmaceuticals, Inc.
Selected listing: PMVP · NASDAQ · USD · US
This page tracks Pmv Pharmaceuticals, Inc.'s PMVP:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PMVP:NASDAQ. PMVP:NASDAQ is the stock-level entry point for investors researching Pmv Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pmv Pharmaceuticals, Inc. is a public company traded under the ticker PMVP in the American market. The company has a market capitalization of approximately $66.1 million. Pmv Pharmaceuticals focuses on developing innovative therapies in the pharmaceutical sector.
- Ticker
- PMVP:NASDAQ
- Asset type
- Stock
- Market cap
- $105.7M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Pmv Pharmaceuticals, Inc. PMVP:NASDAQ stock context
This page tracks Pmv Pharmaceuticals, Inc.'s PMVP:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PMVP:NASDAQ. PMVP:NASDAQ is the stock-level entry point for investors researching Pmv Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pmv Pharmaceuticals, Inc. is a public company traded under the ticker PMVP in the American market. The company has a market capitalization of approximately $66.1 million. Pmv Pharmaceuticals focuses on developing innovative therapies in the pharmaceutical sector.
Latest news from Pmv Pharmaceuticals, Inc.
PMV Pharmaceuticals Appoints Philip Herman as Chief Commercial Officer
September 8, 2026
PMV Pharma Announces Pricing of Oversubscribed $50 Million Public Offering of Securities
August 31, 2026
PMV Pharma Announces Proposed Public Offering of Securities
August 31, 2026
PMV Pharmaceuticals Announces Updated Promising Rezatapopt Monotherapy Interim Ovarian Cancer Data From PYNNACLE Phase 2 Pivotal Trial
August 31, 2026
PMV Pharmaceuticals Reports Second Quarter 2026 Financial Results and Corporate Highlights
August 14, 2026
Research Pmv Pharmaceuticals, Inc.
Pmv Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for PMVP:NASDAQ.
Pmv Pharmaceuticals, Inc. company profile
View the public company page for Pmv Pharmaceuticals, Inc. on 6ix.
Pmv Pharmaceuticals, Inc. news
Read company news and market updates connected to Pmv Pharmaceuticals, Inc..
Pmv Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Pmv Pharmaceuticals, Inc..